Clinical trial
Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients…
NCT00378235 · INSYS Therapeutics Inc, Industry · Withdrawn
Key facts
| NCT number | NCT00378235 |
|---|---|
| Title | Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant Glioma |
| Official title | Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant Glioma |
| Lead sponsor | INSYS Therapeutics Inc, Industry |
| Collaborators | Pediatric Brain Tumor Consortium (PBTC), St. Jude Children's Research Hospital |
| Status | Withdrawn |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Recurrent Malignant Glioma |
| Intervention type | Drug |
| Interventions | IL13-PE38QQR |
| Enrollment | 0 |
| First posted | Sep 19, 2006 |
| Last update posted | Nov 13, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: